Brent Wood obtained his MD and PhD from Loma Linda University followed by a residency in Anatomic and Clinical Pathology at the University of Washington in Seattle. After a fellowship in Hematopathology at the University of Washington, Dr. Wood was on faculty for 25 years in the Department of Laboratory Medicine at the University of Washington where he was Professor and Director of the Hematopathology and Seattle Cancer Care Alliance Laboratories. Currently Dr. Wood is Director of Hematopathology at Childrens Hospital Los Angeles and is on the faculty at the University of Southern California where his responsibilities include clinical service work, translational research, and trainee education. Flow cytometry and minimal residual disease detection are areas of particular interest. He is responsible for implementing the first use of 10 color flow cytometry in the clinical laboratory and exploiting its potential for the identification of minimal residual disease in acute lymphoid leukemia and acute myeloid leukemia. His laboratory serves as a national reference laboratory for the identification of minimal residual disease in childhood acute lymphoblastic leukemia for the Children’s Oncology Group, performs similar testing for other cooperative oncology groups, and provides contract testing for a number of biotechnology and pharmaceutical companies. Dr. Wood lectures both nationally and internationally on clinical applications of flow cytometry and is Past President of the International Clinical Cytometry Society.